✦ LIBER ✦

A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients

✍ Scribed by A. Zori Comba; C. Blajman; E. Richardet; S. Bella; M. Vilanova; F. Cóppola; M. Van Kooten; J. Rodger; R. Giglio; L. Balbiani; F. Perazzo; M. Montiel; M. Chacón; F. Pujol; E. Mickiewicz; E. Cazap; G. Recondo; F. Lastiri; J. Simon; E. Wasserman; A. Schmilovich

Book ID: 117657203
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 134 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)00080-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of irinotecan plus chro

A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients

✍ Garufi, C; Bria, E; Vanni, B; Zappalà, A M R; Sperduti, I; Terzoli, E 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB

Phase I/II study of first-line irinoteca

Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer

✍ Thomas Kuehr; Paul Ruff; Bernardo L Rapoport; Stephen Falk; Francis Daniel; Conr 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 304 KB

Front-line Bevacizumab in combination wi

Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

✍ Christos Emmanouilides; Georgia Sfakiotaki; Nikolaos Androulakis; Kostas Kalbaki 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 263 KB

A multicenter phase II clinical study of

A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as second-line treatment for advanced colorectal cancer: A Japanese experience

✍ Yutaka Ogata; Shoji Tokunaga; Yasunori Emi; Eiji Oki; Hiroshi Saeki; Ken Shirabe 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 188 KB

A multicenter phase II clinical study of

A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as first-line treatment for advanced colorectal cancer: A Japanese experience

✍ Hideo Baba; Naoko Hayashi; Yasunori Emi; Yoshihiro Kakeji; Akinori Egashira; Eij 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 143 KB

Sequential chemotherapy with dose-dense

Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial

✍ Matteo Dalla Chiesa; Gianluca Tomasello; Sebastiano Buti; Rodrigo Kraft Rovere; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 277 KB